Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks
Stoffel, Sandro Tiziano; von Moos, Roger; Thürlimann, Beat; Cathomas, Richard; Gillessen, Silke; Zürrer-Härdi, Ursina; von Briel, Thomas; Anchisi, Sandro; Feller, Anita; Schär, Corinne; Dietrich, Daniel; Schwenkglenks, Matthias; Lupatsch, Judith E.; Mark, Michael Thomas
2021
Patterns of care and economic consequences of using bone-targeted agents for castration-sensitive prostate cancer patients with bone metastases to prevent skeletal-related events in Switzerland - the SAKK 95/16 prostate study
Barbier, Michaela Carla; Pardo, Esther; Panje, Cédric Michael; Gautschi, Oliver; Lupatsch, Judith Eva; Swiss Group for Clinical Cancer Research (SAKK),
2021
A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland.
The European journal of health economics : HEPAC : health economics in prevention and care
Panje, Cedric M.; Dedes, Konstantin J.; Matter-Walstra, Klazien; Schwenkglenks, Matthias; Gautschi, Oliver; Siano, Marco; Aebersold, Daniel M.; Plasswilm, Ludwig; Lupatsch, Judith E.
2018
A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC)
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
